Results 21 to 30 of about 1,119,893 (198)

Comparative study of efficacy of intravenous iron sucrose versus ferric carboxymaltose in the treatment of iron deficiency anaemia

Haematology Journal of Bangladesh, 2020
Background: Iron deficiency anaemia (IDA) is a common haematological complication with potentially serious clinical consequences that may require intravenous iron therapy.
Huque Mahfuz, Mohammad Elias Hossain, Mohammed Mosleh Uddin, Mostafil Karim   +3 more
doaj   +1 more source

Intravenous Iron Sucrose Induced Bullous Pemphigoid

Journal of Applied Hematology, 2021
Pemphigus is an autoimmune bullous disease that may be influenced by multitude of genetic and exogenous factors. Drug induced pemphigus also holds a center stage. With culprit molecule varying from penicillamine to various thiol associated drugs, management mainly revolves around proper history elicitation and prompt ...
Kaustav Saha, Shatavisa Mukherjee
openaire   +2 more sources

Evaluation of Efficacy of Intravenous Iron Sucrose in Management of Adolescent Iron Deficiency Anaemia [PDF]

Journal of Clinical and Diagnostic Research, 2017
Introduction: Worldwide, most common nutritional deficiency anaemia is iron deficiency anaemia. Anaemia in adolescent girls is defined as blood haemoglobin (Hb) level
SAUBHAGYA KUMAR JENA, ARATI MALLICK, SUSHREE SANGEETA ROUT   +2 more
doaj   +1 more source

Safety and efficacy of high-dose intravenous iron carboxymaltose vs. iron sucrose for treatment of postpartum anemia [PDF]

, 2012
The purpose of this study is to compare the safety and efficacy of intravenous (IV) high-dose iron carboxymaltose (ICM) with iron sucrose (IS) for the treatment of postpartum ...
Pfenniger, Anita, Schuller, Christine, Christoph, Patricia, Surbek, Daniel   +3 more
core   +3 more sources

To evaluate the efficacy and safety of intravenous ferrous carboxymaltose compared with Iron sucrose in treating iron deficiency anemia in postpartum period

Asian Journal of Medical Sciences, 2022
Background: Iron deficiency anemia continues to be a serious problem in developing countries resulting in spectrum of adverse events in pregnant women. The first choice for prophylaxis and treatment of mild IDA in pregnancy is oral iron therapy. However,
Akriti Gupta , Ashkrit Gupta , Uttara Gupta , Anand Gupta   +3 more
doaj   +1 more source

Cost-minimization analysis in iron-deficiency anemia comparing intravenous ferric carboxymaltose to standard of care in pregnant women in Algeria

Journal of Applied Hematology, 2023
INTRODUCTION: Anemia due to iron deficiency is frequent during pregnancy and increases morbidity and mortality of mothers and infants. The objective of this study was to assess the economic consequences of intravenous ferric carboxymaltose (FCM) in ...
Lama Aladham, Nacera Benmouhoub, Mohamed Bradai, Amel Dammene-Debbih, Issam Frigaa, Karim Layaida, Lamine Mahi   +6 more
doaj   +1 more source

Iron Status and Analysis of Efficacy and Safety of Ferric Carboxymaltose Treatment in Patients with Inflammatory Bowel Disease [PDF]

, 2011
Background and Aims:We analyzed iron deficiency and the therapeutic response following intravenous ferric carboxymaltose in a large single-center inflammatory bowel disease (IBD) cohort.
Brand, Stephan, Burkhard Göke, Breiteneicher, Simone, Göke, Burkhard, Ochsenkühn, Thomas, Fabian Schnitzler, Stephan Brand, Maria Weidinger, Thomas Ochsenkühn, Simone Breiteneicher, Beigel, Florian, Weidinger, Maria, Schnitzler, Fabian, Löhr, Beate, Seiderer, Julia, Laubender, Rüdiger P., Beate Löhr, Tillack, Cornelia, Cornelia Tillack, Florian Beigel, Julia Seiderer, Rüdiger P. Laubender   +21 more
core   +1 more source

Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency [PDF]

, 2020
Iron deficiency and iron-deficiency anemia are associated with increased morbidity and mortality in a wide range of conditions. In many patient populations, this can be treated effectively with oral iron supplementation; but in patients who are unable to
Macdougall, Iain C, Spahn, Donat R; https://orcid.org/, Koutroubakis, Ioannis E, Comin-Colet, Josep, Breymann, Christian   +4 more
core   +3 more sources

Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy [PDF]

Pediatric Blood & Cancer, 2010
AbstractBackgroundFor decades, parenteral iron has been used in patients with iron deficiency unresponsive to oral iron therapy and in hemodialysis‐dependent patients receiving erythropoietin. Newer intravenous (IV) iron formulations such as iron sucrose have replaced high‐molecular weight iron (HMW) dextran in dialysis patients; however, the use of ...
Shelley E, Crary, Katherine, Hall, George R, Buchanan   +2 more
openaire   +2 more sources

Efficacy and safety of high dose accelerated intravenous iron sucrose in patients of iron deficiency anemia [PDF]

, 2017
Background: Low dose (200 mg) extended Intravenous iron sucrose remains the most common treatment option in patients who are intolerant to oral iron therapy in patients with Iron deficiency anemia (IDA).
Mohd Tahir Ganayie, Naik, Muzafar, Bhat, Arif, Mir Waseem, Tahir Ganayie, Mohd, Muzafar Naik, Waseem, Mir, Tariq Bhat, Bhat, Tariq, Ummer Jalalie, Arif Bhat, Jalalie, Ummer   +11 more
core   +1 more source